Wellington Management Group LLP Sells 26,381 Shares of U.S. Physical Therapy, Inc. $USPH

Wellington Management Group LLP trimmed its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 23.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,496 shares of the company’s stock after selling 26,381 shares during the period. Wellington Management Group LLP owned approximately 0.59% of U.S. Physical Therapy worth $6,078,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. William Blair Investment Management LLC lifted its position in U.S. Physical Therapy by 7.2% during the fourth quarter. William Blair Investment Management LLC now owns 370,707 shares of the company’s stock valued at $28,949,000 after purchasing an additional 24,848 shares during the last quarter. CenterBook Partners LP increased its holdings in shares of U.S. Physical Therapy by 582.7% in the 4th quarter. CenterBook Partners LP now owns 41,284 shares of the company’s stock worth $3,224,000 after buying an additional 35,237 shares during the last quarter. Renaissance Technologies LLC increased its holdings in shares of U.S. Physical Therapy by 23.4% in the 1st quarter. Renaissance Technologies LLC now owns 76,956 shares of the company’s stock worth $5,769,000 after buying an additional 14,582 shares during the last quarter. BlackRock Inc. bought a new stake in shares of U.S. Physical Therapy in the 2nd quarter worth about $155,505,000. Finally, Bank of America Corp DE raised its position in shares of U.S. Physical Therapy by 10.9% during the 1st quarter. Bank of America Corp DE now owns 554,621 shares of the company’s stock valued at $41,574,000 after buying an additional 54,656 shares in the last quarter.

U.S. Physical Therapy Price Performance

USPH stock opened at $77.83 on Thursday. U.S. Physical Therapy, Inc. has a 12 month low of $58.19 and a 12 month high of $93.50. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.48. The company has a 50-day moving average price of $76.82 and a 200 day moving average price of $73.17. The stock has a market cap of $1.16 billion, a PE ratio of 457.88, a P/E/G ratio of 2.17 and a beta of 1.13.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.06). U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The firm had revenue of $214.06 million for the quarter, compared to the consensus estimate of $211.36 million. During the same quarter in the previous year, the company posted $0.81 earnings per share. The business’s revenue for the quarter was up 8.5% on a year-over-year basis. Equities research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.95 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 21st will be paid a dividend of $0.46 per share. The ex-dividend date of this dividend is Friday, August 21st. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.4%. U.S. Physical Therapy’s dividend payout ratio is currently 1,082.35%.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Citizens Jmp reaffirmed a “market outperform” rating and issued a $98.00 price target on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 26th. Finally, Barrington Research boosted their target price on U.S. Physical Therapy from $90.00 to $98.00 and gave the company an “outperform” rating in a research report on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, U.S. Physical Therapy presently has an average rating of “Moderate Buy” and an average target price of $99.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.